Spok Holdings Inc. Common Stock (SPOK)

FairStock Score: 48/100 — MIXED

Key Financials

Strengths

• Generates $18 million in annual free cash flow (7.7% yield on market cap)
• Solid return on equity of 10.6% above cost of capital
• Conservative balance sheet with debt-to-equity of just 0.05, providing financial flexibility
• Attractive 11.0% dividend yield providing steady income returns

Concerns

• Revenue declining at 0.1% year-over-year signals potential demand weakness or market share loss

AI Analysis

Spok Holdings Inc. Common Stock is a micro-cap healthcare company valued at $235 million. The business generates $140 million in annual revenue with a 2.1% net margin and $18 million in free cash flow. From a quality standpoint, Spok shows Altman Z-Score of 2.9 in the grey zone and adequate 11% ROE. On valuation, the stock is reasonably priced at 15.2x earnings, with trades above its Graham Number with a negative 4% margin. Growth dynamics show revenue growing at -0.1% and profit growth of -19.6%. The 11.0% dividend yield adds an income component for patient holders. Our composite FairStock Score of 48/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $18 million in annual free cash flow (7.7% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer